Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q1- Text added to 2020 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accessible, adsorbed, advantage, affordable, Ahead, allogenic, alpha, anogenital, Assistant, background, BARDA, Bio, Biomedical, Bioscience, biotechnology, BV, ccRCC, challenged, characterized, checkpoint, cisplatin, clear, CMV, committed, composed, concomitantly, concurrent, Conference, conjugate, coupled, criteria, CRL, dampening, dedicated, developmental, dimeglumine, Dr, elicited, engineered, epithelial, Flavor, fosaprepitant, GmbH, Greater, growing, healthy, hematology, hematopoietic, highly, IAVI, immunocompromised, immunogenicity, influenza, innovative, intramuscular, islatravir, ISPPD, joinder, JPN, Justice, Labor, laboratory, lag, library, licensure, lieu, low, memorandum, Ministry, Moderna, month, NGM, nonmetastatic, nonprofit, NRTTI, nucleoside, oropharyngeal, Pasteur, people, platform, Pneumococci, PRC, preclinical, procedure, randomized, reached, recovery, Reddy, repeated, Ridgeback, RNA, rVSV, SAR, Science, Secretary, Sentinel, Silgard, sNDA, Spectrum, stem, storage, stream, subdermal, Sun, switched, Symposium, technology, temperature, tolerability, transcriptase, translocation, transplant, unchallenged, underway, unmet, untreated, urgent, vector, vesicular, VHL, viral, Virbac, von, Week, Welfare, withdrawn
Removed:
Afferent, aprepitant, beginning, buying, drove, glargine, insulin, making, obtained, proceeding, submitted, subpoena
Valuein 2020 Q1 filing- Value in 2020 Q2 filing
Original filings
Filing view